News 
Market Data 
Discover
north40000
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
| Ticker | Board | News | Price | Change | Chg% | Added | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMRN | Amarin Corp Plc | 0.8931 | -0.0255 | -2.78% | 03/03/2021 | |||||
| AMLN | Amylin Pharmaceuticals Inc. | 08/28/2012 | ||||||||
|
My AMLN Pitch: One of leading T2Diabetes and obesity-focused companies. Underwent takeover examination by >5 companies [AZN,NVS,BMY,SNY,MRK], reported bids >$25/share. BMY/AZN TO @$31/share expired 08/07. I accumulated in many tranches since 1995; basis for 85% of holdings is $6.60/share. Shares now gone @$31.
|
||||||||||
| Ariad Pharmaceuticals Inc fka ARIA | 02/15/2017 | |||||||||
|
My Pitch: Our basis is $2.29. I am confident of share price increase predicated on upcoming catalysts at FDA, recent financing and potential buy-out. Doubled holdings on 11/07/2013. Takeda agrees to acquire ARIA: $24/share
http://tinyurl.com/jrahcmc |
||||||||||
| CDMO | Avid Bioservices Inc | 7.02 | 0.22 | 3.24% | 01/15/2018 | |||||
|
My CDMO Pitch: http://ih.advfn.com/p.php?pid=nmona&article=55726349
http://www.peregrineinc.com/images/stories/pdfs/2013_asco_breast.pdf 2016 ASM:http://tinyurl.com/z3nv3g9 AACR 2017: http://tinyurl.com/jxfm3hb Exosome studies; Cancer diagnostic:https://tinyurl.com/yd3n5kbk https://tinyurl.com/ya6tgxxa |
||||||||||
| CPRX | Catalyst Pharmaceutical Partners | 15.6 | 0.21 | 1.36% | 09/02/2014 | |||||
|
My CPRX Pitch: http://tinyurl.com/o6guvhe
|
||||||||||
| GILD | Gilead Sciences Inc | 67.5 | -0.25 | -0.37% | 05/02/2018 | |||||
|
My GILD Pitch: Our basis is split-adjusted $0.758/share, acquired 06-1996.GILD's Focus is on treatments for HIV, HCV, HBV, Oncology, future acquisitions. http://tinyurl.com/jva7ron; http://www.gilead.com/
https://tinyurl.com/ya7oeqms |
||||||||||
| INSM | Insmed Inc | 26.375 | -0.445 | -1.66% | 08/12/2010 | |||||
| IBM | International Business Machines | 184.35 | 3.1 | 1.71% | 01/24/2012 | |||||
| JNJ | Johnson and Johnson | 144.4825 | -3.1075 | -2.11% | 08/12/2010 | |||||
| Ocata Therapeutics Inc fka OCAT | 03/04/2016 | |||||||||
|
My Pitch: http://tinyurl.com/gsvoj2l
http://tinyurl.com/luke478 http://tinyurl.com/n6zc5dd http://tinyurl.com/mvk6ul4 http://www.futuremedicine.com/doi/pdf/10.2217/rme.14.89 http://stemcellassays.com/2015/03/products-pipeline-ocata-rpe/ http://tinyurl.com/onobvuq Astellas TO successful @ $8.50, 01/20 |
||||||||||
| SGEN | Seagen Inc | 0 | 0 | 0.00% | 06/14/2012 | |||||
|
My SGEN Pitch: http://finance.yahoo.com/news/seattle-genetics-highlights-updated-survival-110000422.html
Our basis is $6.30. |
||||||||||
| SBUX | Starbucks Corporation | 85.93 | 0.76 | 0.89% | 03/04/2016 | |||||
|
My SBUX Pitch: Our split-adjusted bases:$2.19 and $2.984.I look forward to its continued global expansion, particularly in Europe, China, Vietnam, Italy and India. Founder Howard Schultz has led turn-around in U.S. Recent earnings and developments: https://news.starbucks.com/
|
||||||||||
| VCEL | Vericel Corp. | 47.2 | -1.5 | -3.08% | 04/12/2018 | |||||
| WFM | Whole Foods Markets | 11/11/2017 | ||||||||
|
My WFM Pitch: We have shopped for groceries at WFM for many years. We like its quality--if you like the company's product chances are you should buy its stock. Our split-adjusted basis is $17.37. AMZN purchased WFM for $42/share in 2017.
|
||||||||||
